Summary:
Medical research study to evaluate the use a new lab assay to measure serum levels in patients taking Humira (adalimumab) for the treatment of their Crohn's Disease.
Qualified Participants Must:
• Be at least 18 years of age
•
Be diagnosed with moderate to severe Crohn's disease
•
Have never taken Humira (Adalimumab) for the treatment of their Crohn's disease
Qualified Participants May Receive:
Compensation for time and travel.